Marburg virus |
|
|
Clinical Trial: TGV Study: Study of the Use of the Quick Diagnostic Test of Influenza and Infection With Respiratory Syncytial Virus (RSV)
This study is not yet open for patient recruitment.
Verified by University Hospital of Rouen December 2005
|
Purpose
| Condition | Intervention |
|---|---|
| Influenza Respiratory Syncytial Virus Infections | Device: RSV respi-strip and Quick-vue influenza |
MedlinePlus related topics: Flu; Respiratory Syncytial Virus Infections
Study Type: Interventional
Study Design: Diagnostic, Non-Randomized, Open Label
Official Title: Exploratory Study of the Use of the Quick Diagnostic Test of the Influenza and the Infection With RSV by the Paediatric Emergency Unit and Their Impact on the Assumption of Responsibility of the Suspect Children of a Viral Infection
Expected Total Enrollment: 950
Study start: December 2005
Eligibility
Inclusion Criteria:
- Age less than 3 years
- Isolated fever
- Infection of the higher air routes (congestive otitis, feverish rhinitides, tracheitis or laryngitis) and/or infection of the lower air routes (cough, pneumonia, bronchitis, asthma)
- Signed consent form
Exclusion Criteria:
- Evocative clinical of a urinary and/or bacterial infection
- Purulent acute otitis media
- Typical acute bronchiolitis
- Suspicion of acute lobar pneumonia
- Acute gastro-enteritis
- Anginas
- Serious chronic respiratory pathology
- Other infection whose etiologic viral diagnosis is established
- Congenital or acquired immunizing deficits
- Congenital cardiopathy
Location and Contact Information
France
CHU ROUEN, Rouen, 76031, France
Christophe MARGUET, Professor, Principal Investigator, University Hospital of Rouen
More Information
Last Updated: December 22, 2005
Record first received: December 8, 2005
ClinicalTrials.gov Identifier: NCT00263900
Health Authority: France: Afssaps - French Health Products Safety Agency
ClinicalTrials.gov processed this record on 2006-01-10
Resources
- Arenaviruses (MayoClinic)

Not Signed In -

